CONSOLIDATED BALANCE SHEETS (UNAUDITED) (EUR €) In Thousands, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013
Current Assets
Cash	€ 1,338	€ 297
Receivable other	280	3,712
Prepaid expenses	101	57
Total current assets	1,719	4,066
Property and equipment, net of accumulated depreciation of E278 at June 30, 2014 and E281 at December 31, 2013	114	117
In-process research and development	2,266	2,266
Goodwill	6,671	6,671
Total assets	10,770	13,120
Current Liabilities
Accounts payable	452	858
Acquisition-related contingent consideration	0	236
Current portion of convertible notes payable to related parties	38,872	39,123
Total current liabilities	39,324	40,217
Shareholders' Equity (Deficit)
Common stock, U.S. $0.01 par value; 850,000,000 shares authorized; issued 303,757,622 at June 30, 2014 and 298,418,813 at December 31, 2013	2,529	2,491
Preferred stock, U.S. $0.01 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Additional paid-in capital	34,130	33,876
Deficit accumulated during the development stage	(65,887)	(64,165)
Accumulated other comprehensive income	674	701
Total shareholders' equity (deficit)	(28,554)	(27,097)
Total liabilities and shareholders' equity (deficit)	€ 10,770	€ 13,120